Literature DB >> 29203684

Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.

M Edip Gurol1.   

Abstract

Entities:  

Keywords:  atrial appendage; atrial fibrillation; hemorrhage; intracranial hemorrhage; prevention; stroke; subdural hematoma

Mesh：

Year:  2017        PMID： 29203684      PMCID： PMC5847291          DOI： 10.1161/STROKEAHA.117.017081

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  54 in total

1.  Anatomic analysis of the left atrial appendage after closure with the LARIAT device.

Authors:  Krzysztof Bartus; Remo L Morelli; Wojciech Szczepanski; Boguslaw Kapelak; Jerzy Sadowski; Randall J Lee
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08

2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 3.  Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.

Authors:  Thorsten Steiner; Jonathan Rosand; Michael Diringer
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

4.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

5.  Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Authors:  Robert G Hart; Hans-Christoph Diener; Sean Yang; Stuart J Connolly; Lars Wallentin; Paul A Reilly; Michael D Ezekowitz; Salim Yusuf
Journal:  Stroke       Date:  2012-04-05       Impact factor: 7.914

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.

Authors:  Graeme J Hankey; Susanna R Stevens; Jonathan P Piccini; Yuliya Lokhnygina; Kenneth W Mahaffey; Jonathan L Halperin; Manesh R Patel; Günter Breithardt; Daniel E Singer; Richard C Becker; Scott D Berkowitz; John F Paolini; Christopher C Nessel; Werner Hacke; Keith A A Fox; Robert M Califf
Journal:  Stroke       Date:  2014-04-17       Impact factor: 7.914

9.  Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.

Authors:  Jan C Purrucker; Kirsten Haas; Timolaos Rizos; Shujah Khan; Marcel Wolf; Michael G Hennerici; Sven Poli; Christoph Kleinschnitz; Thorsten Steiner; Peter U Heuschmann; Roland Veltkamp
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

10.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245
View more
  11 in total

1.  Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem.

Authors:  M Edip Gurol
Journal:  Stroke       Date:  2018-05-08       Impact factor: 7.914

Review 2.  Multiple Faces of Cerebral Small Vessel Diseases.

Authors:  M Edip Gurol; Ralph L Sacco; Louise D McCullough
Journal:  Stroke       Date:  2019-11-22       Impact factor: 7.914

3.  The role of biomarkers and neuroimaging in ischemic/hemorrhagic risk assessment for cardiovascular/cerebrovascular disease prevention.

Authors:  Elif Gokcal; Mitchell J Horn; M Edip Gurol
Journal:  Handb Clin Neurol       Date:  2021

Review 4.  A practical approach to the management of cerebral amyloid angiopathy.

Authors:  Mariel G Kozberg; Valentina Perosa; M Edip Gurol; Susanne J van Veluw
Journal:  Int J Stroke       Date:  2020-11-29       Impact factor: 6.948

5.  Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.

Authors:  Vivek Y Reddy; Ronald L Akehurst; Stacey L Amorosi; Meghan B Gavaghan; Deanna S Hertz; David R Holmes
Journal:  Stroke       Date:  2018-05-08       Impact factor: 7.914

6.  Updates on Prevention of Hemorrhagic and Lacunar Strokes.

Authors:  Hsin-Hsi Tsai; Jong S Kim; Eric Jouvent; M Edip Gurol
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

7.  Updates on Prevention of Cardioembolic Strokes.

Authors:  Mehmet Akif Topcuoglu; Liping Liu; Dong-Eog Kim; M Edip Gurol
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

8.  Advances in Stroke Prevention in 2018.

Authors:  M Edip Gurol; Jong S Kim
Journal:  J Stroke       Date:  2018-05       Impact factor: 6.967

9.  Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study.

Authors:  Hsin-Hsi Tsai; Marco Pasi; Li-Kai Tsai; Ya-Fang Chen; Bo-Ching Lee; Sung-Chun Tang; Panagiotis Fotiadis; Chen-Yu Huang; Ruoh-Fang Yen; Jiann-Shing Jeng; M Edip Gurol
Journal:  Neurology       Date:  2019-01-23       Impact factor: 11.800

10.  Risk factors for intracerebral hemorrhage in patients with COVID-19.

Authors:  Kara R Melmed; Meng Cao; Siddhant Dogra; Ruina Zhang; Shadi Yaghi; Ariane Lewis; Rajan Jain; Seda Bilaloglu; Ji Chen; Barry M Czeisler; Eytan Raz; Aaron Lord; Jeffrey S Berger; Jennifer A Frontera
Journal:  J Thromb Thrombolysis       Date:  2020-09-24       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.